BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Robert Mark
Current InstitutionWyeth Phamaceuticals
Current DepartmentWyeth Phamaceuticals Department
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
01/A2/C/07025 The role of Scar proteins in neuronal cell migration and survival Co-Supervisor 39,359 Studentships
terms and conditions of use (opens in new window)
export PDF file